Literature DB >> 16458868

Prostanoid signal transduction and gene expression in the endothelium: role in cardiovascular diseases.

Arántzazu Alfranca1, Miguel A Iñiguez, Manuel Fresno, Juan Miguel Redondo.   

Abstract

Endothelial cells play an active role in the maintenance of homeostasis. Endothelial injury can give rise to endothelial dysfunction in which the profile of mediators released by endothelial cells is altered. Among these mediators are factors that participate in the development of many cardiovascular disorders. Some of the most important are the prostanoids, which can modulate the progression of atherosclerosis, arterial hypertension, and angiogenesis. Prostanoids are produced by the sequential actions of cyclooxygenases and specific synthases and exert their actions through diverse cell-surface and nuclear receptors. The profile of prostanoids produced depends on cell type and the changing pathophysiological status, and these factors similarly affect the great array of biological responses elicited by these molecules. The resulting complexity enables extremely subtle and highly complex responses, and this provides opportunities for the development of targeted therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16458868     DOI: 10.1016/j.cardiores.2005.12.020

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  35 in total

Review 1.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.

Authors:  Takayuki Matsumoto; Styliani Goulopoulou; Kumiko Taguchi; Rita C Tostes; Tsuneo Kobayashi
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

2.  Resistance of cyclooxygenase-2 expressing pancreatic ductal adenocarcinoma cells against γδ T cell cytotoxicity.

Authors:  Daniel Gonnermann; Hans-Heinrich Oberg; Christian Kellner; Matthias Peipp; Susanne Sebens; Dieter Kabelitz; Daniela Wesch
Journal:  Oncoimmunology       Date:  2015-01-07       Impact factor: 8.110

3.  Acyl chain-dependent effect of lysophosphatidylcholine on endothelial prostacyclin production.

Authors:  Monika Riederer; Pauli J Ojala; Andelko Hrzenjak; Wolfgang F Graier; Roland Malli; Michaela Tritscher; Martin Hermansson; Bernhard Watzer; Horst Schweer; Gernot Desoye; Akos Heinemann; Sasa Frank
Journal:  J Lipid Res       Date:  2010-07-07       Impact factor: 5.922

4.  PGI₂ signaling inhibits antigen uptake and increases migration of immature dendritic cells.

Authors:  Shinji Toki; Kasia Goleniewska; Matthew M Huckabee; Weisong Zhou; Dawn C Newcomb; Garret A Fitzgerald; William E Lawson; R Stokes Peebles
Journal:  J Leukoc Biol       Date:  2013-04-26       Impact factor: 4.962

5.  The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation.

Authors:  Anna Theiler; Viktoria Konya; Lisa Pasterk; Jovana Maric; Thomas Bärnthaler; Ilse Lanz; Wolfgang Platzer; Rufina Schuligoi; Akos Heinemann
Journal:  Vascul Pharmacol       Date:  2016-09-21       Impact factor: 5.773

6.  Cyclooxygenase 2, toll-like receptor 4 and interleukin 1β mRNA expression in atherosclerotic plaques of type 2 diabetic patients.

Authors:  Alessandro Baldan; Silvia Ferronato; Silvia Olivato; Giovanni Malerba; Alberto Scuro; Gian Franco Veraldi; Matteo Gelati; Sergio Ferrari; Sara Mariotto; Pier Franco Pignatti; Sara Mazzucco; Macarena Gomez-Lira
Journal:  Inflamm Res       Date:  2014-08-06       Impact factor: 4.575

7.  Prostaglandins PGE(2) and PGI(2) promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation.

Authors:  Anna A Birukova; Tatiana Zagranichnaya; Panfeng Fu; Elena Alekseeva; Weiguo Chen; Jeffrey R Jacobson; Konstantin G Birukov
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

8.  Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells.

Authors:  Helen M Reid; B Therese Kinsella
Journal:  Br J Pharmacol       Date:  2009-08-20       Impact factor: 8.739

9.  Thromboxane A2 receptor activates a Rho-associated kinase/LKB1/PTEN pathway to attenuate endothelium insulin signaling.

Authors:  Ping Song; Miao Zhang; Shuangxi Wang; Jian Xu; Hyoung Chul Choi; Ming-Hui Zou
Journal:  J Biol Chem       Date:  2009-04-29       Impact factor: 5.157

10.  Endothelium modulates vasoconstrictor response to prostaglandin I2 in rat mesenteric resistance arteries: interaction between EP1 and TP receptors.

Authors:  F E Xavier; J Blanco-Rivero; M Ferrer; G Balfagón
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.